Long-term outcomes of mitral valve replacement in dialysis patients: evidence from a nationwide database

被引:0
作者
Yang, Kelvin J. [1 ]
Fu, Hsun-Yi [2 ]
Chang, Chia-Jui [3 ,4 ]
Wang, Ting-Chuan [5 ]
Wang, Chih-Hsien [1 ]
Chou, Nai-Kuan [1 ]
Wu, I-Hui [1 ]
Hsu, Ron-Bin [1 ]
Huang, Shu-Chien [1 ]
Yu, Hsi-Yu [1 ]
Chen, Yih-Sharng [1 ]
Chi, Nai-Hsin [1 ,6 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Cardiovasc Surg, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Cardiovasc Surg, Hsin Chu Branch, Hsinchu, Taiwan
[3] Natl Taiwan Univ, Grad Inst Clin Pharm, Coll Med, Taipei, Taiwan
[4] Natl Taiwan Univ, Canc Ctr, Dept Pharm, Taipei, Taiwan
[5] Natl Taiwan Univ, Hlth Data Res Ctr, Taipei, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Surg, 8 Chung Shan S Rd, Taipei, Taiwan
关键词
end-stage renal disease; hemodialysis; mitral valve; prosthetic valve; valve replacement; STAGE RENAL-DISEASE; AMERICAN-HEART-ASSOCIATION; TASK-FORCE; MANAGEMENT; GUIDELINES; SURVIVAL; KIDNEY;
D O I
10.1097/JS9.0000000000000684
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: To compare the late outcomes between mechanical and bioprostheses after isolated mitral valve replacement (MVR) in dialysis-dependent patients. Methods: A nationwide propensity-matched retrospective cohort study was conducted involving dialysis patients who underwent primary mitral replacement between 2001 and 2018. Ten-year postoperative outcomes were compared between mitral bioprosthesis and mechanical prosthesis using the Cox proportional hazard model and restricted mean survival time (RMST). Results: The all-cause mortality was 20.8 and 13.0 events per 100 person-years, with a 10-year RMST of 7.40 and 7.31 years for bioprosthesis and mechanical prosthesis, respectively. Major bleeding was the most common adverse event for both bioprosthesis and mechanical prosthesis, with an incidence rate of 19.5 and 19.1 events per 100 person-years, respectively. The incidence of valve reoperation was higher among those who received bioprosthesis (0.55 events per 100 person-years). After 1:1 matching, the all-cause mortality was 15.45 and 14.54 events per 100 person-years for bioprosthesis and mechanical prosthesis, respectively. The RMST at 10 years was comparable between the two groups after matching (5.10 years for bioprosthesis vs. 4.59 years for mechanical prosthesis), with an RMST difference of -0.03. Further, no difference was observed in the incidence of major adverse valve-related events between bioprosthesis and mechanical valves. However, bioprosthesis was associated with a higher incidence of mitral valve reoperation among all major adverse events (RMST difference -0.24 years, 95% CI -0.48 to -0.01, P=0.047). Conclusions: This study found no association between valve selection and long-term survival outcomes in dialysis patients after MVR. However, bioprosthetic valves may be associated with a slightly higher incidence of reoperation, while other valve-related adverse events, including major bleeding and stroke, were comparable between the two types of prostheses.
引用
收藏
页码:3778 / 3787
页数:10
相关论文
共 50 条
  • [41] Short- and long-term outcome after surgical aortic valve replacement in patients on dialysis
    Perrotta, Sossio
    Nielsen, Susanne J.
    Hansson, Emma C.
    Lepore, Vincenzo
    Martinsson, Andreas
    Jeppsson, Anders
    Lindgren, Martin
    JOURNAL OF THORACIC DISEASE, 2021,
  • [42] Perioperative and long-term outcomes of Ross versus mechanical aortic valve replacement
    Wenos, Chelsea D.
    Herrmann, Jeremy L.
    Timsina, Lava R.
    Patel, Parth M.
    Fehrenbacher, John W.
    Brown, John W.
    JOURNAL OF CARDIAC SURGERY, 2022, 37 (10) : 2963 - 2971
  • [43] In patients undergoing dialysis who require a valve replacement is a bioprosthetic valve superior to a mechanical prosthesis in terms of long-term survival and morbidity?
    Fong, Laura S.
    Ang, Zhen Hao
    Wolfenden, Hugh
    Akhunji, Zakir
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2020, 31 (02) : 174 - 178
  • [44] Gastrointestinal bleeding in patients on long-term dialysis
    Trivedi, Hariprasad
    Yang, Juliana
    Szabo, Aniko
    JOURNAL OF NEPHROLOGY, 2015, 28 (02) : 235 - 243
  • [45] Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement
    Campos Guimaraes, Leonardo de Freitas
    Urena, Marina
    Wijeysundera, Harindra C.
    Munoz-Garcia, Antonio
    Serra, Vicenc
    Benitez, Luis M.
    Auffret, Vincent
    Cheema, Asim N.
    Amat-Santos, Ignacio J.
    Fisher, Quentin
    Himbert, Dominique
    Garcia del Blanco, Bruno
    Dager, Antonio
    Le Breton, Herve
    Paradis, Jean-Michel
    Dumont, Eric
    Pibarot, Philippe
    Rodes-Cabau, Josep
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (09)
  • [46] Long-term survival after mitral valve replacement in children aged <5 years
    Caldarone, CA
    Raghuveer, G
    Hills, CB
    Atkins, DL
    Burns, TL
    Behrendt, DM
    Moller, JH
    CIRCULATION, 2001, 104 (12) : I143 - I147
  • [47] Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes
    Murphy, Alexandra C.
    Koshy, Anoop N.
    Cameron, William
    Horrigan, Mark
    Kearney, Leighton
    Yeo, Belinda
    Farouque, Omar
    Yudi, Matias B.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (01) : 157 - 164
  • [48] Long-term outcomes of patients undergoing tricuspid valve surgery
    Saran, Nishant
    Dearani, Joseph A.
    Said, Sameh M.
    Greason, Kevin L.
    Pochettino, Alberto
    Stulak, Johnm.
    Maltais, Simon
    Cicek, Sertac
    Crestanello, Juan
    Daly, Richard C.
    King, Katherine S.
    Schaff, Hartzell V.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2019, 56 (05) : 950 - 958
  • [49] Long-term outcomes of surgical valve replacement in patients with severe carcinoid heart disease
    Matti, J.
    Crompton, J.
    O'Mahony, Furtado L.
    Hayes, A.
    Harrison, T.
    Kolvekar, S.
    Wong, K.
    Mandair, D.
    Caplin, M.
    Davar, J.
    Toumpanakis, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 250 - 250
  • [50] Long-term outcomes of rheumatic mitral valve repair: Is it worthwhile to do it?
    Waikittipong, Somchai
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2021, 29 (02) : 91 - 97